Suppression of Release of Radioactive Iodine as a Test of Thyroid Function*
- 1 January 1962
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 22 (1) , 26-30
- https://doi.org/10.1210/jcem-22-1-26
Abstract
Sixteen euthyroid and 19 thyrotoxic subjects were given a tracer dose of radioactive iodine and the 24-hour thyroidal I131 uptake was determined. Immediately after the 24-hour uptake was measured, the subjects were given 25 μg of triiodothyronine every 8 hours and 30 mg of methimazole every 6 hours. Thyroidal radioactivity was determined periodically thereafter. Seven days after administration of the tracer, 92 (±1.8) per cent of the labeled iodine remained in the thyroids of the euthroid subjects whereas only 49.1 (±3.8) per cent was retained by the thyrotoxic patients. The difference between the two groups was sufficiently great to be of diagnostic value. Suppression, by thyroid hormone, of the release rather than the uptake of I131 offers several practical advantages as a diagnostic test.Keywords
This publication has 1 reference indexed in Scilit:
- QUANTITATIVE OBSERVATIONS WITH THE TRIIODOTHYRONINE SUPPRESSION TEST OF THYROID FUNCTION*Journal of Clinical Endocrinology & Metabolism, 1961